2022
DOI: 10.31219/osf.io/35kfz
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Why Glutamate-Oxaloacetate Transaminase can be used as a biomarker for liver damage?

Abstract: Glutamate-Oxaloacetate Transaminase is a biomarker for organ damage. However, the underlying mechanism is not fully known. The rise of Glutamate-Oxaloacetate Transaminase activity enhances the conversion of oxaloacetate to aspartic acid, resulting in lower levels of oxalate from breakdown of oxaloacetate. The insoluble and stiff calcium oxalate was proposed as a cause of cell senescence and death. Therefore, Glutamate-Oxaloacetate Transaminase reduces stress generated from energy metabolism, serving as a self-… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles